Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences Medical Device Investing
Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates Life Science Investing
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results Life Science Investing
Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update Life Science Investing
Maze Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights Life Science Investing
aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update Life Science Investing
Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer Life Science Investing
Incyte's Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema Life Science Investing
